Menu
Not yet recruiting NCT06947525

Effects of Shotblocker and Manual Pressure on Pain and Satisfaction

No phase Interventional Pain Satisfaction

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Manual pressure, Shotblocker.
Who it may be relevant to
Registry conditions: Pain, Satisfaction. Basic parameters: 18 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Effects of Shotblocker and Manual Pressure on Pain and Satisfaction During Peripheral Venous Catheter Placement: A Randomized Controlled Trial

Overview

This study aims to determine the effects of shotblocker and manual pressure applied during peripheral venous catheter placement on pain and satisfaction. 81 patients hospitalized in the Urology clinic will be included in the study. Patients will be assigned to three groups as shotblocker (n=27), manual pressure (n=27) and control group (n=27) by block randomization method. Research Hypotheses * H1-1: The mean pain scores of the intervention group to which shotblocker was applied during peripheral intravenous catheterization are different from the control group. * H1-2: The mean pain scores of the intervention group to which manual pressure was applied during peripheral intravenous catheterization are different from the control group. * H1-3: The mean satisfaction scores of the intervention group to which shotblocker was applied during peripheral intravenous catheterization are different from the control group. * H1-4: The mean satisfaction scores of the intervention group to which manual pressure was applied during peripheral intravenous catheterization are different from the control group.

Interventions

  • Other Manual pressure
    Before the procedure in the manual pressure group, the vein entry area will be pressed with the right hand thumb for 10 seconds. The pressure will be applied until the nail bed turns white.
  • Other Shotblocker
    In the Shotblocker group, the shotblocker will be placed 2 cm above the vein entry point and will remain throughout the procedure.

Primary outcome measures

  • Visual Analog Scale (VAS) [Time frame: The peripheral venous catheter will be filled within 1 minute after insertion.]
Secondary outcome measures (1)
  • Patient Satisfaction Scale [Time frame: The peripheral venous catheter will be filled within 1 minute after insertion.]

Eligibility criteria

Inclusion criteria

  • Admission to the urology clinic,
  • No verbal, perceptual and visual communication problems,
  • Between the ages of 18 and 65,
  • Literate,
  • Volunteer to participate in the study,
  • Not using medication that will create a chronic analgesic effect,
  • Not having chronic or acute pain,
  • No intervention has been performed on the vein where the PIC is placed in the last month,
  • No scar tissue or infection in the areas where the PIC will be placed,
  • Not having a disease that will cause problems in feeling pain (such as neuropathy)

Exclusion criteria

  • The individual wants to leave the study,
  • Feels unwell during the PIC placement (such as dizziness, palpitations),
  • Uses sedatives or alcohol,

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Prevention

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT06947525 · NecErUn

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗